Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioAmber Inc. BIOAQ

BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints... see more

OTCPK:BIOAQ - Post Discussion

BioAmber Inc. > Eye-Catching Stock:Bioamber By Bret WilsherFebruary 13, 2018
View:
Post by Jamesson on Feb 13, 2018 3:37pm

Eye-Catching Stock:Bioamber By Bret WilsherFebruary 13, 2018

Bioamber Inc (NYSE:BIOA) has average revenue estimates of $3.3 Million, compared to low analyst estimates of $6.75 Million and high estimates of $6.75 Million for the current quarter. A total number of 1 analysts provided estimations over revenues. For the current year the company’s revenue estimates are $15.27 Million compared to low analyst estimates of $14.5 Million and high estimates of $16.04 Million according to the prediction of 2 analysts.

Taking a broader look at the analyst consensus, according to 3 analysts Bioamber Inc (NYSE:BIOA)’s price will reach at $6.67 during 52 weeks. Its minimum price target estimates has been figured out at $1 while the maximum price target forecast is established at $12.

Comment by Montrose9 on Feb 13, 2018 10:24pm
candle pattern suggests a move to 25 cents that needs to fill a gap to 50 cents meaning most in at higher prices will sell above 20 cents
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities